Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Athersys Inc
(NQ:
ATHX
)
2.080
USD
-0.170 (-7.56%)
Official Closing Price
Updated: 7:57 PM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Athersys Inc
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Athersys Announces Cooperation Agreement With HEALIOS K.K.
February 16, 2021
Athersys and Healios commit to work in good faith to finalize negotiations important to successful commercialization in Japan.
From
Business Wire News Releases
Athersys Announces CEO Transition
February 16, 2021
Gil Van Bokkelen to Step Down as Chairman and CEO of Athersys
From
Business Wire News Releases
How The Pieces Add Up: LABU Headed For $205
February 11, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Athersys to Host a Virtual Investor Day
January 28, 2021
Athersys will host a virtual investor day event on February 16th to cover development progress and commercial manufacturing plans.
From
Business Wire News Releases
38 Stocks Moving in Tuesday's Pre-Market Session
January 26, 2021
Gainers Koss Corporation (NASDAQ: KOSS) shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the ...
Tags
LPCN
ALNA
MBI
From
Benzinga
First Week of March 19th Options Trading For Athersys (ATHX)
January 19, 2021
Investors in Athersys Inc (ATHX) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options...
Tags
Stocks
From
Market News Video
The Math Shows XBI Can Go To $186
December 22, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Market Briefing For Tuesday, Dec. 22
December 22, 2020
Big-caps remain extended, as bears continue 'fighting the Fed', even as for sure, a post-Expiration pause would be normal, but Tesla might mix that up.
Tags
Technology
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Why Athersys Stock Jumped Today
December 21, 2020
The biotech announced the enrollment of the first patient in a key clinical study.
Tags
Market News
ATHX
From
Motley Fool
4 Best Penny Stocks To Buy Right Now? Analyst Targets Up To 246%
December 21, 2020
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
December 21, 2020
UTHealth and Athersys announce patient enrollment in an innovative clinical study of MultiStem® cell therapy for the treatment of traumatic injuries
From
Business Wire News Releases
Market Briefing For Monday, Dec. 21
December 21, 2020
History is replete with those who tried to make the market go their way at a time when more powerful forces argued otherwise.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
4 Penny Stocks To Buy According To Analysts; 48%-463% Price Targets
November 25, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Healthcare Stocks Moving In Wednesday's After-Market Session
November 18, 2020
Gainers Corcept Therapeutics (NASDAQ:CORT) shares rose 22.99% to $22.95 during Wednesday's after-market session. At the close, ...
Tags
Market News
BIOL
LNTH
From
Benzinga
Athersys Announces Three Appointments to Board of Directors
November 16, 2020
Athersys announces three appointments to its board of directors, deepening board expertise to prepare for future growth and commercialization.
From
Business Wire News Releases
Athersys Reports Third Quarter 2020 Results and Provides Corporate Update
November 09, 2020
Athersys announces Q3 earnings and initiation of MultiStem® Phase 2 clinical trial in patients with trauma related inflammation and complications
From
Business Wire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
ALGS
IBB
PLXP
From
Benzinga
Athersys to Host Third Quarter Financial Results Call
October 08, 2020
Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2020 financial results on Monday, November 9, 2020.
From
Business Wire News Releases
44 Stocks Moving In Wednesday's Mid-Day Session
September 23, 2020
Gainers Spi Energy Co Ltd (NASDAQ: SPI) shares climbed 718.5% to $8.43 after the company launched a new electric vehicle ...
Tags
CBAT
Benzinga
News
From
Benzinga
Return On Capital Employed Overview: Athersys
September 23, 2020
During Q2, Athersys's (NASDAQ: ATHX) reported sales totaled $84.00 thousand. Despite a 16.36% in earnings, the company posted a loss ...
Tags
ATHX
Benzinga
Earnings
From
Benzinga
Thinking about buying stock in Athersys, Party City, AcelRx Pharmaceuticals, Southwest Airlines, or Carnival Corp?
September 23, 2020
InvestorsObserver issues critical PriceWatch Alerts for ATHX, PRTY, ACRX, LUV, and CCL.
From
PR Newswire
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
September 23, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ESALY
GNFT
CSTL
From
Benzinga
38 Stocks Moving in Wednesday's Pre-Market Session
September 23, 2020
Gainers Predictive Oncology Inc. (NASDAQ: POAI) shares rose 43.1% to $1.21 in pre-market trading after the company secured ...
Tags
ZI
EXK
NAOV
From
Benzinga
FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome
September 23, 2020
MultiStem is the only cell therapy program for acute respiratory distress syndrome (ARDS) that has both Fast Track and RMAT designation from the FDA.
From
Business Wire News Releases
First Week of ATHX November 20th Options Trading
September 18, 2020
Investors in Athersys Inc (ATHX) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options...
Tags
Stocks
From
Market News Video
The Math Shows XBI Can Go To $161
September 18, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Sum Up The Pieces: VHT Could Be Worth $228
August 18, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Athersys (ATHX) Q2 2020 Earnings Call Transcript
August 11, 2020
ATHX earnings call for the period ending June 30, 2020.
Tags
ATHX
Market News
From
Motley Fool
Athersys Reports Second Quarter 2020 Results
August 10, 2020
Athersys has made progress during Q2 in key clinical programs and infrastructure to support its planned transition to becoming a commercial company.
From
Business Wire News Releases
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
August 09, 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ...
Tags
UROV
RLAY
TXG
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.